ABG

Ally Bridge Group Portfolio holdings

AUM $114M
1-Year Return 41.64%
This Quarter Return
+5%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$413M
AUM Growth
+$25.1M
Cap. Flow
+$35.5M
Cap. Flow %
8.59%
Top 10 Hldgs %
62.35%
Holding
38
New
8
Increased
6
Reduced
6
Closed
5

Top Buys

1
NUVB icon
Nuvation Bio
NUVB
$20.9M
2
VRDN icon
Viridian Therapeutics
VRDN
$11.4M
3
CVAC icon
CureVac
CVAC
$10.1M
4
BOLT icon
Bolt Biotherapeutics
BOLT
$9.47M
5
EPIX icon
ESSA Pharma
EPIX
$8.28M

Top Sells

1
AUPH icon
Aurinia Pharmaceuticals
AUPH
$11.9M
2
CSTL icon
Castle Biosciences
CSTL
$7.53M
3
VIR icon
Vir Biotechnology
VIR
$7.37M
4
AVIR icon
Atea Pharmaceuticals
AVIR
$6.98M
5
LUNG icon
Pulmonx
LUNG
$6.41M

Sector Composition

1 Healthcare 97.96%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ACET icon
26
Adicet Bio
ACET
$59.8M
$5.56M 1.07%
+425,000
New +$5.56M
FRLN
27
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$5.03M 0.96%
27,248
-1,085
-4% -$200K
IMVT icon
28
Immunovant
IMVT
$2.99B
$4.17M 0.8%
+260,000
New +$4.17M
ORTX
29
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$3.97M 0.76%
54,743
– –
LUNG icon
30
Pulmonx
LUNG
$70.1M
$2.7M 0.52%
58,939
-140,183
-70% -$6.41M
IDYA icon
31
IDEAYA Biosciences
IDYA
$2.35B
$705K 0.14%
+30,000
New +$705K
AUPH icon
32
Aurinia Pharmaceuticals
AUPH
$1.65B
– –
-858,032
Closed -$11.9M
SRPT icon
33
Sarepta Therapeutics
SRPT
$1.95B
– –
0
– –
VIR icon
34
Vir Biotechnology
VIR
$740M
– –
-275,000
Closed -$7.37M
XNTK icon
35
SPDR NYSE Technology ETF
XNTK
$1.26B
– –
0
– –
NSTG
36
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-9,277
Closed -$620K
ONCT
37
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
– –
-15,000
Closed -$1.47M
KDNY
38
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-199,600
Closed -$3.17M
1
2